ArticleFrontiers in medicine2026
Clinical study of remimazolam combined with ultrasound-guided superior laryngeal nerve block in elderly patients with coronary heart disease undergoing bronchoscopy.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To investigate the efficacy and safety of remimazolam combined with ultrasound-guided superior laryngeal nerve block (SLNB) during bronchoscopic procedures in elderly patients with coronary heart disease. Methods: A total of 99 elderly patients with coronary heart disease who underwent a flexible bronchoscopy procedure at the First Hospital of Shanxi Medical University from March 2025 to August 2025 were enrolled and randomly divided into three groups ( Results: No significant differences were observed in baseline characteristics among the three groups ( Discussion: Ultrasound-guided superior laryngeal nerve block combined with remimazolam for bronchoscopy in elderly patients with coronary heart disease helps maintain hemodynamic stability, suppresses coughing, reduces adverse reactions, shortens recovery time, lowers remifentanil consumption and hypoxemia incidence, and enhances anesthesia satisfaction, suggesting that this regimen may be a feasible option for bronchoscopy sedation. Although transient differences in early postoperative cognitive screening scores were observed, their clinical significance remains unclear and warrants cautious interpretation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.